These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 125860)

  • 1. [Antithrombogenic action of a new extract: 3GS].
    Rusconi C; Orlando G
    Minerva Cardioangiol; 1975 Sep; 23(9):565-70. PubMed ID: 125860
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical research on the aged concerning the anti-sclerotic effect of a new heparinoid extract: glycuronoglucosaminoglycan sulfate (3GS)].
    Turpini R; Caliandro L; Cocchi A; Volpi F; Brusaioli G; Grignani G; Antognetti R
    Clin Ter; 1975 May; 73(3):213-36. PubMed ID: 123842
    [No Abstract]   [Full Text] [Related]  

  • 3. [The use of glucuronyl-glucosamino-glycan sulfate (3GS) in the treatment of cerebral and peripheral athero-arteriosclerotic pathology].
    Ciammaichella A; Solitro A; Torcia L; Arcuri P
    Clin Ter; 1978 Mar; 84(5):509-21. PubMed ID: 648104
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clearing and anti-platelet-aggregation effects of a heparinoid of natural origin].
    Marini U; Bastoni F; Gibelli A
    Clin Ter; 1974 Oct; 71(1):13-31. PubMed ID: 4138995
    [No Abstract]   [Full Text] [Related]  

  • 5. [Glucuronyl-glucosaminoglycan sulfate in therapy of atheroarteriosclerotic syndromes in geriatrics].
    Bompani R; Violi G
    Minerva Med; 1974 Nov; 65(83):4315-29. PubMed ID: 4279362
    [No Abstract]   [Full Text] [Related]  

  • 6. [Fibrinolytic therapy of arteriosclerosis. Influence on hemocoagulation of a total arterial wall extract for oral use].
    Guglielmi G; Barlattani M; Garbagnati N; Iaschi P; Ciavarelli F
    Clin Ter; 1969 Sep; 50(6):527-36. PubMed ID: 5406050
    [No Abstract]   [Full Text] [Related]  

  • 7. [Activity of glucuronyl-glucosamine-glycan sulfate in patients with dyslipemia. Medium-term study].
    Pedrazzi F; Bonazzi L; Peterlin F
    Clin Ter; 1975 May; 73(4):327-42. PubMed ID: 1240795
    [No Abstract]   [Full Text] [Related]  

  • 8. [Therapy of arteriosclerotic vasculopathies with arterial wall extract].
    Veccia F
    Clin Ter; 1967 Sep; 42(5):429-42. PubMed ID: 5617689
    [No Abstract]   [Full Text] [Related]  

  • 9. [Miscleron in the treatment of patients with atherosclerosis of the coronary and cerebal vessels].
    Sivkov II; Kukes VG; Kirichenko LL; Fedosova NS; Ishmaeva KA
    Sov Med; 1971 Sep; 34(9):54-7. PubMed ID: 5121295
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical experiences on the anti-dyslipidemic effect of a new sulfomucopolysaccharide of pancreatic origin].
    Castello S
    Clin Ter; 1971 Aug; 58(4):323-34. PubMed ID: 4258171
    [No Abstract]   [Full Text] [Related]  

  • 11. [Current problems of antithrombotic therapy].
    Liusov VA; Belousov IuB
    Kardiologiia; 1981 Aug; 21(8):5-17. PubMed ID: 7026869
    [No Abstract]   [Full Text] [Related]  

  • 12. [Thrombodensitographic changes during treatment with a coumarin derivative].
    Ferri F; Regazzini A
    Minerva Med; 1970 Jan; 61(8):309-18. PubMed ID: 4189912
    [No Abstract]   [Full Text] [Related]  

  • 13. [Heparinoids in the treatment of dyslipemia in patients with diabetic vasculopathy: action of 3gs].
    Cavazzini MG
    Clin Ter; 1978 Jan; 84(1):41-64. PubMed ID: 75777
    [No Abstract]   [Full Text] [Related]  

  • 14. [Hyperlipemia and hypofibrinolysis in arteriosclerotic disease].
    Prino G; Mantovani M
    Boll Chim Farm; 1967 Feb; 106(2):67-84. PubMed ID: 4893083
    [No Abstract]   [Full Text] [Related]  

  • 15. [Study of the activity of a sulfomucopolysaccharide extractive on the blood-lipid and fibrinolytic pattern in atherosclerotic disease].
    Isidori A; Recchia O; Butti A
    Minerva Med; 1967 Mar; 58(19):779-82. PubMed ID: 4164416
    [No Abstract]   [Full Text] [Related]  

  • 16. [Checking of various hemostatic indices in patients with vascular diseases before and after treatment with inhibitors of platelet adhesiveness].
    Patrone F; Armani U; Boy E; Botta G; Boccaccio P
    Minerva Cardioangiol; 1975; 23(6-7):379-91. PubMed ID: 1143662
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical testing of 2 drugs with angiotrophic and regulatory action on vascular metabolism in hypertensive myocardioangiosclerosis].
    Puleo F; Intravaia S
    G Gerontol; 1970 Dec; 18(12):1133-8. PubMed ID: 5517043
    [No Abstract]   [Full Text] [Related]  

  • 18. [Prolonged therapeutic-prophylactic use of anticoagulants].
    Kushelevskiĭ BP; Seliverstova GP
    Klin Med (Mosk); 1973 Apr; 51(4):26-8. PubMed ID: 4704262
    [No Abstract]   [Full Text] [Related]  

  • 19. [Combined intenkordin and corhormone treatment of ischemic heart disease].
    Glukhen'kiĭ TT; Kuz'ko NV
    Vrach Delo; 1974 May; 5(0):55-7. PubMed ID: 4407764
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effect of anabolic steroid preparations on blood coagulation processes].
    Karacharov AT
    Klin Med (Mosk); 1971 Oct; 49(10):131-4. PubMed ID: 5133136
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.